🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Recent drug approvals for #DMD lack follow-up data or fail to meet #clinicaltrial #endpoints. The need for new ways to measure treatment success is crucial. #Emmes has developed the #Duchenne Video Assessment to address this demand. Learn more hubs.la/Q02pSfqm0 #RareDisease

Collaborate with our team of #Vaccine & #InfectiousDisease experts with 35+ years of experience providing leadership & full-service support. Our flexible, rapid approach & deep expertise have successfully met accelerated timelines for #clinicaltrials. hubs.la/Q02qkgbK0

Discover how the #Emmes #Vaccine & #InfectiousDisease team initiated a study within 8 weeks & adapted their #DataManagement approach during a rapidly changing pandemic to deliver crucial biostatistical data. Read our case study to learn more: hubs.la/Q02r3Bgy0

Accelerate your start-up plan for #vaccines & #infectiousdiseases with this whitepaper. Discover how to select the right #CROpartner with a robust data platform & trial site connections. Secure a long-term collaboration confidently. hubs.la/Q02rvNqV0

#Emmes will be attending the 55th #ASAM24 April 4&5, 2024 in Dallas, TX. We are looking forward to connecting with industry and government leaders, understanding the current state of science and exploring innovative ideas. #CROpartner

Meet us at #ARVO24, booth #1606. We’d love to discuss how we can bring our experience to you and help you run your next #ophthalmology #clinicaltrial. Book a meeting at ARVO with our team of ophthalmology experts here: hubs.ly/Q02sg1jQ0 #CROPartner

Reach out to Matt Donnelly, BD, Neuroscience to discuss your upcoming clinical development plans & gain valuable insights about how #Emmes can support your next clinical trial. hubs.ly/Q02sjj6v0

Working on clinical studies for #Ophthalmology? Our expert team & cutting-edge technology are revolutionizing #ClinicalTrials. Connect with us at #ARVO24 Booth #1606 to discuss your impactful work in ophthalmic research. Click here to schedule a meeting:hubs.la/Q02sCj9B0

#Emmes is advancing ophthalmic research forward by combining our vast expertise and cutting-edge technology. Meet us at #ARVO24 booth #1606 to discuss how we can partner on your next #Ophthalmology #ClinicalTrial. Book a meeting here: hubs.la/Q02vqPtx0

Watch the interview with Courtney Nelson-Douthit, Sr Global Project Mgr, discussing major advancements in #clinicalneuroscience. Learn her role in an MDD Psilocybin study featured in 2023 JAMA & new treatment options for children with cerebral palsy from a Phase 3 #clinicaltrial.

Watch the interview w/ Dominic Ippolito, #Neuroscience Project Leader, to see how Emmes works with clients to design & execute successful #clinicaltrials. Discover how Emmes uses a unified #datamanagement platform & AI technology to meet clients' unique needs & advance research.

Don't miss the chance to learn from leading expert at #ASGCT2024. Gain valuable insights for your #CellTherapy & #GeneTherapy clinical trial program during our engaging talks at booth #226. Unable to attend? Schedule a meeting hubs.la/Q02wn89r0 #ClinicalTrial #CROpartner

Day 2 of #ASGCT2024 is off to a great start! Stop by booth #226 to discuss our CRO services and how we can partner with you on your cell and gene therapy clinical trial program. #CellTherapy #GeneTherapy #ClinicalTrial #CROpartner #SCD #SickleCellDisease

We are excited to share this interview with Steffanie Wilson, VP, Neuroscience Therapeutic Area Lead, highlighting our innovative work in #clinicalneuroscience research and the impact of our AI tools on advancing decentralized #clinicaltrials. #CROpartner #HorizonsPBC

Jeanine May, Natalia De Val, & Karen Stablein are at the #MTEC Conference discussing Emmes' expertise in conducting #clinicalresearch that meets regulatory guidelines at NIH & DoD. Stop by their poster today between 4:15-8:00pm. #infectiousdiseases #clinicalneuroscience.

Excited to share Kathryn Hefner, Senior Project Leader Scientist's interview on Emmes' involvement in the #ClinicalTrials Network for a substance use disorder study & the impact on clinical practices for opioid use disorder. #CROpartner #HorizonsPBC #ClinicalNeuroscience

Excited to announce that outcomes from the NCI-AMC ANCHOR study, where Emmes served as the Data Management Center, has resulted in a revision of the CDC's guidelines for anal cancer screening & prevention. Click the link below to find out more. hubs.la/Q02Gx-h70

At Emmes, we’re transforming the future of cell & gene therapy! With 20+ years of partnership w/ the NIH & established connections to 100+ blood & marrow transplantation centers, we’re at the forefront of advancing innovative treatments. Schedule a meeting tinyurl.com/53hxw74v

Emmes is hiring a Project Leader with NeuroHIV experience to lead groundbreaking Neuroscience research. Join us in supporting the National NeuroHIV Tissue Consortium Data Coordinating Center. Click the link to learn more about this exciting opportunity: hubs.la/Q02YcT_J0

We are happy to share that Germaine Gross has been appointed as the new Chief Commercial Officer of Emmes Biopharma. #PressRelease #LeadershipAnnouncement hubs.la/Q032Jbxs0